Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 425
Selected: 0
NCT IDTitle
NCT00025298Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
NCT00062231Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
NCT02172872"InDACtion" vs "3+7" Induction in AML
NCT00182819Radiation Therapy or Temozolomide in Treating Patients With Gliomas
NCT00626730Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma
NCT00002777Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
NCT02218801A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program
NCT00014612Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer
NCT00003589Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00003418Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
NCT00948389Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)
NCT00002623Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
NCT00002462RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
NCT04128072Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma
NCT04402073Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma
NCT00027781MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00002651SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
NCT00005584Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
NCT02394626Surgery for Recurrent Glioblastoma
NCT01101425Male Breast Cancer: Understanding the Biology for Improved Patient Care
NCT00689221Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status
NCT03345095A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
NCT04097093Long-term Surival of GIST Patients ≥ 10 Years on Imatinib
NCT00005052Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
NCT01850004Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response
NCT01979393IRCI Gynae Sarcomas, High Grade Uterine Sarcoma
NCT06783348Radiopharmaceutical Treatment of Advanced Kidney Cancer
NCT05270044Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
NCT00004885Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer
NCT00074087Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
NCT02205047Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma
NCT01658527TAK-700 in Castration Resistant Prostate Cancer
NCT00004179Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00003982MEN-10755 in Treating Patients With Solid Tumors
NCT01142414Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence
NCT01597414Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1
NCT00053807Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
NCT00025636Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma
NCT03319316Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC)
NCT02856867Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN)
NCT00003636Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT00389688Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery
NCT00949962Post-operative or Early Salvage XRT and ADT for High Risk PCa
NCT00003729Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia
NCT00014300Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme
NCT00006477Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors
NCT00263822Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer
NCT04740372Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ
NCT03488810Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer
NCT05259605Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification